Recombinant Human B-lymphocyte antigen CD19 (CD19), partial, Biotinylated
Recombinant Human B-lymphocyte antigen CD19 (CD19), partial, Biotinylated is a purified Recombinant Protein. Purity: >95% as determined by SDS-PAGE. Host: Mammalian cell. Endotoxin Level: Not Tested. Species: Human (Homo sapiens) . Target Name: B-lymphocyte antigen CD19 (CD19), Biotinylated. Accession Number: P15391; CD19. Expression Region: 20-291aa. Tag Info: C-terminal hFc-Avi-tagged. Theoretical MW: 57.9kda. Target Synonyms: B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD antigen CD19 Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
Recombinant Human B-lymphocyte antigen CD19 (CD19), partial, Biotinylated is a purified Recombinant Protein.
Accession Number
P15391; CD19
Expression Region
20-291aa
Host
Mammalian Cells
Target
B-lymphocyte antigen CD19 (CD19), Biotinylated
Conjugation
Unconjugated
Tag
C-Terminal hFc-Avi-Tagged
Field of Research
Immunology
Endotoxin
Not Tested
Purity
>95% by SDS-PAGE
Activity
Not Tested
Length
Partial
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
57.9kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD antigen CD19
Species
Human (Homo sapiens)
Protein Name
Recombinant Protein
AA Sequence
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Xpress™ Human MBOAT4 Over-expressing Stable Cell Line